Orchestrating oral chronic graft-versus-host disease: the tryptophan connection

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective treatment for blood cancers. However, a common and serious side effect called chronic Graft-Versus-Host Disease (cGVHD) affects up to half of the patients who receive this treatment. In cGVHD, the donor's immune cells attack the patient's body, often targeting the mouth. This leads to significant pain, difficulty eating, and a lower quality of life. The exact processes for this condition are not well understood, making it difficult to develop potential treatments and prevention. Our study aimed to uncover the mechanism of oral cGVHD by investigating at changes in small molecules and immune responses in patients who had undergone allo-HSCT. We collected saliva and oral tissue samples from 14 patients at different stages: before the transplant, six months after, one year after, and when cGVHD symptoms appeared. We discovered that certain molecules, especially those involved in inflammation, were significantly different in patients who developed cGVHD compared to those who did not. Specifically, we found that the balance of a particular pathway related to the amino acid including tryptophan and kynurenine was disrupted in cGVHD patients. The imbalance correlated with changes in the levels of various inflammatory markers. Our findings suggest that monitoring these specific molecules could help in early diagnosis and better management of oral cGVHD. Understanding these changes could lead to the development of targeted treatments, improving the lives of patients undergoing allo-HSCT by reducing the severity of cGVHD and its impact on their daily lives. Future research is essential to validate these results and to further investigate the role of microbial interactions in this process.